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Abstract
Background: Several neurodegenerative diseases are influenced by complex genetics that affect
an individual's susceptibility, disease severity, and rate of progression. One such disease is
glaucoma, a chronic neurodegenerative condition of the eye that targets and stimulates apoptosis
of CNS neurons called retinal ganglion cells. Since ganglion cell death is intrinsic, it is reasonable
that the genes that control this process may contribute to the complex genetics that affect ganglion
cell susceptibility to disease. To determine if genetic background influences susceptibility to optic
nerve damage, leading to ganglion cell death, we performed optic nerve crush on 15 different inbred
lines of mice and measured ganglion cell loss. Resistant and susceptible strains were used in a
reciprocal breeding strategy to examine the inheritance pattern of the resistance phenotype.
Because earlier studies had implicated Bax as a susceptibility allele for ganglion cell death in the
chronic neurodegenerative disease glaucoma, we conducted allelic segregation analysis and mRNA
quantification to assess this gene as a candidate for the cell death phenotype.
Results: Inbred lines showed varying levels of susceptibility to optic nerve crush. DBA/2J mice
were most resistant and BALB/cByJ mice were most susceptible. F1 mice from these lines inherited
the DBA/2J phenotype, while N2 backcross mice exhibited the BALB/cByJ phenotype. F2 mice
exhibited an intermediate phenotype. A Wright Formula calculation suggested as few as 2 dominant
loci were linked to the resistance phenotype, which was corroborated by a Punnett Square analysis
of the distribution of the mean phenotype in each cross. The levels of latent Bax mRNA were the
same in both lines, and Bax alleles did not segregate with phenotype in N2 and F2 mice.
Conclusion: Inbred mice show different levels of resistance to optic nerve crush. The resistance
phenotype is heritable in a dominant fashion involving relatively few loci. Bax was excluded as a
candidate gene for this phenotype.
Background
The influence of complex genetics on neurodegenerative
diseases such as Alzheimer's Disease, Parkinson's Disease,
and Multiple Sclerosis, is evidenced by the consideration
that family history is a significant risk factor for candidate
patients [1-3]. Although interacting loci may influence a
variety of different factors, one common element is the
process of neuronal cell death, which predominantly
occurs by apoptosis [4,5]. Consequently, consideration of
the genes that affect susceptibility to disease should
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include those that affect both the response(s) of neurons
to damaging stimuli and the process of cell death itself.
Several studies, using screening strategies of inbred mouse
lines, have reinforced the concept that genetic background
has an influence on the level of susceptibility to neuronal
damage [6-9]. At least 3 loci have been mapped, for exam-
ple, that affect neuronal susceptibility to the Parkinsonian
neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrid-
ine (MPTP) [10,11].
Primary open angle glaucoma is also a multifactorial neu-
rodegenerative disease with a strong familial component
[12-14]. This disease affects an estimated 60 million indi-
viduals worldwide [15] and is characterized by the pro-
gressive apoptotic death of retinal ganglion cells and the
degeneration of the optic nerve [16-18]. All forms of glau-
coma are associated with critical elevations in intraocular
pressure (IOP), but humans exhibit a wide range of sus-
ceptibility to this stimulus. Although most glaucoma
patients have a higher than average IOP, the majority of
ocular hypertensives will never develop the disease
[19,20]. Conversely, there is a significant percentage of
glaucoma sufferers who have normal or below normal
IOP [17]. In the majority of people with glaucoma, how-
ever, lowering IOP regardless of the starting level, has a
beneficial effect in slowing the progression of the disease.
This clinical history of disease progression and response
to treatment has led to the concept that there is variable
susceptibility to the damaging effects of eye pressure [20-
22].
One genetically regulated component that could influ-
ence ganglion cell susceptibility is the cell death process
itself. In response to a majority of cell death stimuli, reti-
nal ganglion cell death in mice is restricted to Bax-depend-
ent, intrinsic apoptosis, a pathway common to many
neurons of the CNS. This pathway is activated during
development [23], after acute optic nerve lesion [24], or in
chronic spontaneous glaucoma [25]. Since apoptosis is an
intrinsic genetic process, differences in alleles of genes
that affect cell death could influence ganglion cell suscep-
tibility to a damaging stimulus. Reducing Bax gene dos-
age, for example, reduces the level of latent Bax mRNA
and can completely abrogate ganglion cell death after
optic nerve crush or in glaucoma [25]. To explore the pos-
sibility that genetic background could affect neuronal cell
death, we first investigated if different strains of inbred
mice exhibited different levels of ganglion cell loss in
response to a standardized lesion of the optic nerve
(mechanical crush). Here, we report that inbred mice have
different susceptibilities to optic nerve crush, and that the
resistant phenotype can be inherited in a relatively simple
Mendelian fashion. Although Bax plays a critical role in
regulating ganglion cell susceptibility, we excluded it as a
candidate gene for this trait. Identification of the gene(s)
that affect the susceptibility of retinal ganglion cells to
damaging stimuli could help elucidate part of the genetic
complexity of glaucoma and other neurodegenerative dis-
eases.
Results
Inbred mice exhibit quantitative differences in ganglion 
cell loss after optic nerve crush
Retinal ganglion cell loss after optic nerve crush occurs
over a period of 3 weeks, with the most rapid period of
loss occurring between the first and second weeks [26].
We chose to examine the period of 2 weeks after optic
nerve crush in order to assess the process of cell death
while still at an intermediate stage (see Methods section).
A bar graph of the mean (± SD) of cells remaining in the
crushed retina for 10 mice in 15 different lines is shown
in Figure 1. Representative micrographs of control and
crushed Nissl-stained retinas from mice at each end and
the middle of this distribution are shown in Figure 2. Mice
exhibited a range of cell loss after 2 weeks from 26.3% to
47.4% of the total neurons in the ganglion cell layer. A
matrix of P values comparing each of the means against
each other (t-tests) is shown in Table 1. Both sets of inbred
lines with similar genetic backgrounds (DBA and C57BL
mice) had comparable amounts of cell loss based on sta-
tistical testing. There were no significant correlations
between coat color and susceptibility or known neurosen-
sory defects and susceptibility (data not shown).
Ganglion cell prevalence in DBA/2J and BALB/cByJ mice
From the initial screen of 15 inbred lines, DBA/2J mice
were selected as the most resistant, and BALB/cByJ mice
were selected as the most susceptible. A potential caveat in
this study, however, is that cell loss was estimated as a per-
centage of the total neurons present in the ganglion cell
layer. Since ganglion cells are not the only neurons
present in this layer, our analysis of cell loss would only
be accurate if ganglion cells comprised a similar percent-
age of the neurons in each strain. To assess this, we calcu-
lated the total number of neurons in the ganglion cell
layers of DBA/2J and BALB/cByJ mice by counting cells in
Nissl-stained whole mounts of untreated retinas. We also
estimated the total number of ganglion cells in each strain
by counting axons in sections of the optic nerves. Results
of this analysis are shown in Table 2. Although DBA/2J
mice have more total neurons in their ganglion cell layer
they also have a proportionately higher number of gan-
glion cells, resulting in the same percentage of ganglion
cells in both strains (~ 60%).
Dominant inheritance of ganglion cell resistance to crush
To confirm these as resistant and susceptible strains, we
performed optic nerve crush on increased numbers of
mice from each strain (28 DBA/2J and 31 BALB/cByJ
mice). Consistent with the initial screen, DBA/2J miceBMC Neuroscience 2007, 8:19 http://www.biomedcentral.com/1471-2202/8/19
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exhibited significantly less cell loss than BALB/cByJ mice
(Figures 3A and 3B, P = 3.8 × 10-8, t test). To determine
whether the susceptibility to optic nerve crush was genet-
ically controlled, crosses were performed between the two
strains. F1 mice (n = 28) inherited the optic nerve crush-
resistance phenotype exhibited by DBA/2J mice (Figure
3C, P = 0.178 vs DBA/2J and P = 0.001 vs BALB/cByJ
mice). N2 mice (n = 55), exhibited a shift toward a more
susceptible phenotype (Figure 3D, P = 2.2 × 10-6 vs DBA/
2J and P = 0.15 vs BALB/cByJ). F2 mice (n = 56) yielded
an intermediate phenotype after optic nerve crush with a
bias toward the resistance phenotype (Figure 3E, P = 0.017
vs DBA/2J and P = 0.006 vs BALB/cByJ). By assigning a
mean value for cell loss for the resistant and susceptible
phenotypes, cell loss in each of the crosses was accurately
predicted by the expected distribution of 2 dominant alle-
les using a Punnett Square method of analysis (data not
shown).
A statistical estimation of the number of affecting loci was
made using a modified Wright Formula, which takes into
account the means and variances of the F1 mice and the
recurrent backcross parental strain [27,28]. This formula
yielded a value of 1.3, suggesting that only a few genes
were contributing to the inheritance pattern of this phe-
notype, consistent with the Punnett Square analysis.
Elimination of Bax as a contributing allele to the resistance 
phenotype
The proapoptotic gene Bax is essential for ganglion cell
death after optic nerve crush [24] and in chronic sponta-
neous glaucoma [25]. Reduced Bax  expression in mice
heterozygous for a Bax knock-out allele has varying effects
on neurons, depending on genetic background [25,29],
an effect that appears to be related to the level of latent Bax
mRNA from the endogenous wild type gene (S. Semaan
and R. Nickells, unpublished observation) [30]. Bax+/-
Inbred mice exhibit different sensitivity to optic nerve crush Figure 1
Inbred mice exhibit different sensitivity to optic nerve crush. Histographs showing the percentage of cells remaining in 
the retinal ganglion cell layer 2 weeks after optic nerve crush. The data shown is the mean (± SD) of 10 mice from each strain 
and reflects the percentage of cells present in the experimental retina relative to the fellow control eye.BMC Neuroscience 2007, 8:19 http://www.biomedcentral.com/1471-2202/8/19
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DBA/2J mice are completely resistant to optic nerve crush
[25] and have relatively low levels of neuronal Bax expres-
sion. Interestingly, DBA/2J mice were the most resistant to
the same crush protocol of all the inbred mice examined.
To examine Bax as a candidate gene for the resistant phe-
notype, we first quantified Bax mRNA levels in the brains
of DBA/2J and BALB/cByJ mice using RNase Protection
Assays (RPA). Both lines express a BAX protein with the
same predicted amino acid sequence (data not shown), so
if Bax was associated with the resistance phenotype, we
predicted that BALB/cByJ mice would have higher levels of
latent neuronal Bax mRNA. Quantitative examination of
Bax mRNA levels in BALB/cByJ and DBA/2J mice showed
no statistical difference between the two lines (P = 0.49,
Figure 4). In a second experiment, we mapped the segre-
gation of DBA/2J (D2) and BALB/cByJ (B) Bax alleles in
N2 and F2 mice used in this study. A scatter plot of phe-
notype as a function of Bax genotype is shown in Figure 5.
Evaluation of these data was made comparing mice with
the BaxB/B background against BaxD2/B and BaxD2/D2 mice
(animals with the D2 allele were either pooled together as
one group or compared as separate groups). None of the
4 possible comparisons yielded a significant association
between the Bax genotype and the resistance phenotype
(ANOVA, P = 0.150 for BaxB/B vs. BaxD2/Band BaxD2/D2 N2
and F2 mice combined, n = 106; P = 0.356 for BaxB/B vs.
BaxD2/B vs. BaxD2/D2 N2 and F2 mice, n = 106; P = 0.987 for
BaxB/B vs. BaxD2/B and BaxD2/D2 F2 mice only, n = 53; and P
= 0.575 for BaxB/B vs. BaxD2/B vs. BaxD2/D2 F2 mice only, n
= 53).
Discussion
We screened 15 different strains of inbred mice for cell
loss caused by optic nerve crush and identified differing
levels of susceptibility. DBA/2J mice were identified as the
most resistant strain, and BALB/cByJ mice were identified
as the most susceptible strain. Offspring of crosses involv-
ing these two lines inherited the resistance phenotype,
while a backcross of the F1 mice to the susceptible paren-
tal strain, yielded a population of mice with the suscepti-
ble phenotype. The progeny of the F1 intercross inherited
an intermediate phenotype with a bias toward resistance.
The pattern of inheritance exhibited by the crosses sug-
Table 1: Matrix of P values of the mean cell counts from all inbred lines
Strain DBA/2J 129X1/
SvJ
C57BL/
10J
DBA/1J C57BL/
6J
MRL/
MpJ
A/J FVB/NJ CBA/CaJ LG/J SJL/J NZB/
BINJ
NOD/
LtJ
C3H/
HeJ
BALB/cByJ 0.00012 0.00017 0.0002 0.00001 0.0008 0.0005 0.0008 0.0001 0.00003 0.0004 0.01 0.015 0.003 0.339
C3H/HeJ 0.001 0.0017 0.0022 0.0005 0.006 0.005 0.007 0.002 0.001 0.005 0.048 0.066 0.05
NOD/LtJ 0.001 0.004 0.004 0.0007 0.015 0.014 0.019 0.0065 0.003 0.013 0.18 0.29
NZB/BINJ 0.0096 0.025 0.033 0.024 0.069 0.08 0.095 0.077 0.07 0.126 0.35
SJL/J 0.022 0.06 0.07 0.08 0.138 0.17 0.189 0.189 0.194 0.265
LG/J 0.04 0.138 0.162 0.187 0.28 0.344 0.36 0.398 0.42
CBA/CaJ 0.034 0.138 0.166 0.209 0.3 0.386 0.4 0.46
FVB/NJ 0.045 0.165 0.197 0.258 0.336 0.42 0.436
A/J 0.087 0.239 0.276 0.359 0.407 0.489
MRL/MpJ 0.079 0.236 0.275 0.365 0.413
C57BL/6J 0.125 0.322 0.363 0.476
DBA/1J 0.088 0.308 0.354
C57BL/10J 0.194 0.458
129X1/SvJ 0.214
A table showing head-to-head statistical comparisons of the mean cells remaining of each strain of inbred mice. P values (t-test) shown in bold font 
indicate a significant difference in the mean values between the compared mice. Based on the criterion of cell loss in the ganglion cell layer 2 weeks 
after crush, DBA/2J mice exhibited the greatest resistance to optic nerve crush, while BALB/cByJ mice exhibited the greatest susceptibility.
Nissl-stained ganglion cell layers from control and experi- mental eyes Figure 2
Nissl-stained ganglion cell layers from control and 
experimental eyes. Each panel is representative of the 
mid-central superior retina of the inbred lines shown. Two 
weeks after optic nerve crush, the retinas exhibit a loss of 
cells with larger somas and nuclei with prominent nucleoli, 
features characteristic of retinal ganglion cells. DBA/2J, SJL/J, 
and BALB/cByJ mice exhibit resistant, moderately resistant, 
and susceptible phenotypes to optic nerve crush, respec-
tively. Magnification 200×.BMC Neuroscience 2007, 8:19 http://www.biomedcentral.com/1471-2202/8/19
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gests involvement of dominant alleles and a Punnett
Square analysis to determine the frequency of inheritance
of 2 dominant genes, with complete penetrance, accu-
rately predicted the mean cell loss observed in each cross.
Similarly, a Wright formula calculation estimated that a
minimum of 1.3 loci were affecting this phenotype. Anal-
ysis of Bax expression level and allelic segregation with
phenotype excluded this gene as a candidate for one of the
affecting alleles.
The Influence of Genetic Background on 
Neurodegeneration in Inbred Mice
Several studies have reported that inbred strains of mice
exhibit variable susceptibility to neurodegenerative stim-
uli, but there has been no consistent correlation between
strain and susceptibility. C57BL/6 mice, which were rela-
tively crush resistant in our study, are more susceptible to
MPTP exposure, spinal chord injury, and experimental
autoimmune encephalitis (EAE) than other strains. Con-
versely, BALB/c mice (crush susceptible) are resistant to
EAE and MPTP, but exhibit a similar susceptibility as
C57BL/6 mice to spinal chord injury. C57BL/10 mice
(crush resistant) and B10.PL mice, which are EAE resistant
and susceptible, respectively, both exhibit less severe
injury after spinal chord lesion than other strains [9]. Part
of the differences exhibited by some inbred strains may
reside in their variable abilities to mount an immune
response, which can affect the progression and severity of
certain neurodegenerative diseases [9,31]. The lack of a
correlation between mouse strains and their susceptibility
to different degenerative challenges is not surprising. Each
challenge is potentially unique to different subsets of neu-
rons (such as cells in the substantia nigra being suscepti-
ble to MPTP). It is also likely that different diseases elicit
different damaging stimuli, which in turn can activate
alternative pathways leading to neuronal death [24,32].
Genes that affect Retinal Ganglion Cell Death
Recently, Libby et al [14] outlined two broad classes of
genes that can affect ganglion cell susceptibility to damage
in glaucoma. The first class modulates extrinsic suscepti-
bility of ganglion cells. This set of genes is predicted to
influence the response of non-ganglion cells (e.g., glia) to
ocular hypertension, the composition and modulation of
the extracellular matrix, the density and regulation of ret-
inal vasculature of the optic nerve head, and possibly the
immune responses in the eye. The second class of genes
modulates the intrinsic susceptibility of ganglion cells.
These latter genes are predicted to directly affect ganglion
cell survival. By the nature of our screen, which directly
activates apoptosis by axonal lesion, we predict that we
are most likely selecting for intrinsic susceptibility genes.
Many genes could be intrinsic susceptibility factors. Reti-
nal ganglion cell death follows the basic molecular path-
ways identified in other neurons and several of the key
genes involved in cell death could affect ganglion cell sus-
ceptibility to damaging stimuli. We examined the Bax
gene as a candidate based on the evidence that this gene
was critical for ganglion cell death in a variety of situations
[23-25]. Several other genes, however, are also known to
influence ganglion cell death. Proapoptotic genes active in
ganglion cells include c-Jun [33,34] and c-JUN terminal
Kinase (Jnk) [35], p53  [36],  Bim  [37],  Apaf-1  [34],
poly(ADP-ribose) polymerase (Parp) [38], and several cas-
pases [39-42]. Interestingly, a significant association has
been reported between p53 (TP53) haplotypes and pri-
mary open angle glaucoma in humans [43].
In addition to proapoptotic genes, ganglion cells are also
significantly affected by the expression of antiapoptotic
genes. Ganglion cells express BclX, whose expression
decreases during the initial stages of apoptosis [44].
Upregulation of this gene in ganglion cells enhances their
survival [45]. Similarly, transgenic mice that overexpress
the BclX homolog, Bcl2, exhibit nearly complete abroga-
tion of ganglion cell death during development and after
optic nerve transection [46,47]. Since downregulation of
endogenous BclX, along with other normally expressed
genes [48,49], is an early event in ganglion cell apoptosis,
Table 2: Total neuron and ganglion cell counts from DBA/2J and BALB/cByJ mice
Strain GCL Neurons* Total Axons** Percent RGCs
DBA/2J 118416 ± 12313 72175 ± 17554 61.0
BALB/cByJ 90788 ± 11200 54740 ± 8484 60.3
A table showing the comparison of total neurons counted in the ganglion cell layer (GCL) and the percentage of this layer that are made up of 
retinal ganglion cells (RGC) in DBA/2J and BALB/cByJ mice. RGCs make up a similar percentage of the neurons present in this layer of both DBA/2J 
and BALB/cByJ mice (61% and 60.3%, respectively), which validates the methodology of quantifying cell loss as a percentage of the total number of 
neurons present in the GCL of each strain.
*Neurons were identified from Nissl-stained whole mounts of untreated retinas and counted. A calculation was made of the neuron density/mm2 
from a minimum of four 200× microscopic fields of at least 30 non-experimental retinas per strain. The total number of neurons was then 
calculated by multiplying the density by the total retinal area measured in the whole mounts using Image Pro software.
**Axon counts were generated from a minimum of three 1000× fields per section (3 sections per nerve) of 5 individual optic nerves per strain. The 
density of the axons was then calculated and total axon number was determined by multiplying the density by the total nerve area measured in the 
section using Image Pro software.BMC Neuroscience 2007, 8:19 http://www.biomedcentral.com/1471-2202/8/19
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any variation that reduces this process and allows these
proteins to persist could affect the normal apoptotic pro-
gram.
Damaged ganglion cells in mammals also exhibit an early
stress response that includes the up-regulation of heat
shock proteins [50,51] and iron-regulating genes includ-
ing transferrin and ceruloplasmin [52,53]. These latter
genes may also act as antioxidants by scavenging free rad-
icals formed from mitochondria during the cell death
process [54].
Although Bax has been eliminated as a candidate gene in
this population of mice, clearly there are other genes that
could affect the cell death phenotype. We are currently in
the process of conducting a genome wide screen to iden-
tify potential loci that affect the resistance phenotype.
Using Mice to Identify Susceptibility Alleles for Glaucoma
In this study, we used inbred mice to assess if genetic back-
ground affects the susceptibility of retinal ganglion cells to
a lesion of the optic nerve. These experiments do not
directly address whether the same genes that affect gan-
glion cells after optic nerve crush will also be susceptibility
alleles for ganglion cells exposed to elevated levels of IOP,
the principal damaging insult in glaucoma. The actual
mechanism linking high IOP with ganglion cell damage is
still unresolved, but some studies suggest that elevated
pressure causes increased sheer forces on the optic nerve
at the level of the scleral canal and lamina cribrosa
[55,56]. This has lead to the hypothesis that increased IOP
Latent Bax mRNA levels are similar in the CNS of DBA/2J  and BALB/cByJ mice Figure 4
Latent Bax mRNA levels are similar in the CNS of 
DBA/2J and BALB/cByJ mice. (A) An ethidium bromide-
stained gel (reverse image) showing the RT-PCR products 
for Bax and S16 mRNAs at increasing numbers of cycles. Bax 
mRNA appears equally abundant in both strains of mice. This 
observation was confirmed with RNase Protection Assays 
(B). The level of Bax message was normalized to the level of 
S16 and this value was plotted for each mouse examined. No 
statistical difference was observed in the Bax mRNA abun-
dance between the two strains (P = 0.98, t-test).
Resistance to optic nerve crush is heritable Figure 3
Resistance to optic nerve crush is heritable. Histo-
graphs showing the distribution of cell loss in 5 different pop-
ulations of mice. (A) DBA/2J parental strain. (B) BALB/cByJ 
parental strain. (C) F1 generation of mice from DBA/2J and 
BALB/cByJ parents. These offspring inherit a level of resist-
ance comparable to the DBA/2J parental strain. (D) N2 back-
cross generation of mice (F1 mice crossed with BALB/cByJ 
mice). These mice exhibit a shift toward the BALB/cByJ pat-
tern of lowered resistance to optic nerve crush. (E) F2 gen-
eration of mice (F1 intercross). These mice exhibit an 
intermediate pattern of resistance.BMC Neuroscience 2007, 8:19 http://www.biomedcentral.com/1471-2202/8/19
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causes mechanical damage to axons at this region [57,58],
and it is becoming more evident that this is the region of
initial damage in glaucoma [59-61]. Although the concept
of sheer stress acting directly on the axons is attractive, and
could be analogous to our crush insult, there are several
other mechanisms by which IOP can induce damage in
this region. These include reducing the perfusion of
microvessels in the nerve head and the focal activation of
astrocytes and microglia. Consequently, it is possible that
optic nerve crush may act differently on ganglion cells
than elevated IOP.
Regardless of the nature of the insult, there is some evi-
dence, however, both optic nerve crush and elevated IOP
result in a similar cell death response within the ganglion
cells themselves. Ganglion cell apoptosis is Bax-depend-
ent [24,25] and leads to the activation of caspases
[39,41,42] in both conditions. In addition, ganglion cells
undergo early losses of gene expression before the activa-
tion of detectable ganglion cell loss [48] after crush and in
glaucoma. In view of the similarities of the cell death
pathways activated by both conditions, we predict that the
susceptibility alleles that affect ganglion cell death after
crush will also affect ganglion cell loss in glaucoma. A crit-
ical test of this hypothesis is to first identify the loci that
affect the crush phenotype and then assess how the same
gene(s) affect ganglion cell loss in glaucoma. For example,
DBA/2J mice naturally develop a form of secondary
Scatter plot showing the distribution of the percent cells remaining as a function of Bax allele and breeding population Figure 5
Scatter plot showing the distribution of the percent cells remaining as a function of Bax allele and breeding 
population. Mice from the N2 backcross and F2 populations were genotyped at position 23.0 on chromosome 7, near the 
location of the Bax allele. Each group of points represents individual animals carrying either a contributing allele from a BALB/
cByJ parent (B) or a DBA/2J parent (D2). ANOVA analysis indicated no significant association between the resistance pheno-
type and the segregation of the Bax allele, excluding this gene as the principal contributor of this phenotype.BMC Neuroscience 2007, 8:19 http://www.biomedcentral.com/1471-2202/8/19
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chronic inherited glaucoma [62-65]. Although DBA/2J
mice are the most resistant strain assayed in our study,
they still exhibit variable susceptibility to elevated IOP as
they age, which eventually leads to ganglion cell loss.
Breeding the susceptibility alleles inherent in BALB/cByJ
mice onto the DBA/2J background, however, could result
in mice that develop a more aggressive form of glaucoma.
Thus, in response to the same levels of elevated IOP, these
modified mice may develop earlier onset of ganglion cell
loss or perhaps an accelerated rate of retinal degeneration.
Conclusion
In summary, our examination of ganglion cell loss after
optic nerve crush in inbred mice indicates that genetic
background influences the susceptibility of these cells.
Experiments using a reciprocal breeding strategy demon-
strate that the resistance phenotype is inherited in a dom-
inant fashion and involves relatively few loci. Extending
this observation to identify the genes at these loci, may
help elucidate some of the alleles that contribute to sus-
ceptibility to ocular hypertension leading to glaucoma in
humans.
Methods
Inbred mice
Animals were handled in accordance with the Association
for Research in Vision and Ophthalmology Statement on
the use of animals for research. All inbred mice were pur-
chased from the Jackson Laboratory (Bar Harbor, ME).
Five female and 5 male mice, aged 6 weeks, were obtained
from each of the following lines: 129X1/2J, A/J, BALB/
cByJ, C3H/HeJ, C57BL/6J, C57BL/10J, CBA/CaJ, DBA/1J,
DBA/2J, FVB/NJ, LG/J, MRL/MpJ, NOD/LtJ, NZB/BINJ,
SJL/J. Lines were chosen to obtain a cross section of mice
with different coat colors, varying degrees of neurosensory
defects (including 8 lines with hearing loss due to
homozygosity for the Cdh23ahl allele and 3 lines with pho-
toreceptor degeneration due to homozygosity for the
Pde6brd1 allele), and at least 2 pairs of lines with similar
genetic backgrounds (C57BL/6J – C57BL/10J and DBA/1J
– DBA/2J). DBA/2J mice also exhibit spontaneous chronic
glaucoma associated with the loss of ganglion cells
[62,65]. This disease affects older mice and was not
expected to influence the response of young mice to an
acute lesion.
Mice were aged to 8 weeks, at which time they underwent
optic nerve crush on the left eye (see below). Mice were
allowed to recover and were maintained for another 2
weeks before being euthanized for cell counting. This pro-
tocol was strictly adhered to for all the mice examined in
this study. New animals were obtained from the Jackson
Laboratory for all matings that required the original
inbred parental strains. A reciprocal breeding strategy was
used for subsequent matings to generate N2 backcrossed
mice (F1 × susceptible parental strain) and F2 mice (F1
intercross).
Optic nerve crush and ganglion cell counting
For optic nerve crush surgery, mice were anesthetized with
ketamine (6 mg/mL) and xylazine (0.4 mg/mL). The
crush protocol was performed as described previously
[26] using an intraorbital approach. Only the left eye of
each mouse underwent the procedure. The loss of gan-
glion cells is a continuous process over a 3–4 week period,
therefore we examined the time point at which there was
the earliest maximum difference between the resistant
and susceptible strains. Both DBA/2J and BALB/cByJ mice
exhibit minimal cell loss at one week, followed by a
period of rapid cell loss between 1 and 2 weeks. Each
strain also exhibits modest cell loss after this point, but
the difference between the two is not different than that
observed at 2 weeks after crush (data not shown). For this
reason, we examined all populations of mice at 2 weeks
after optic nerve crush.
To quantify cell loss, mice were euthanized and the supe-
rior region of each eye was marked with an ophthalmic
cautery prior to enucleation. Each eye was then enucleated
and fixed for 1 h at 22°C in 4% paraformaldehyde in 0.1
M phosphate buffer (pH 7.4) containing 100 mM NaCl
(PBS) followed by rinsing in PBS. An eyecup of the poste-
rior pole was isolated and incubated in PBS containing
0.3% TritonX-100 (v/v), overnight at 22°C. Following
incubation, the retina was dissected and mounted (gan-
glion cell layer up) on a glass "Plus" slide (Fisher Scien-
tific, Chicago, IL), dried, and flattened under a coverslip
weighted with a 10 g weight [66]. Dry retinas were stained
by painting them with 1% cresyl violet acetate in 0.25%
acetic acid [67]. Stained retinas were then differentiated
and dehydrated in 100% ethanol, cleared in xylene, and
coverslipped. Each slide contained the control and exper-
imental retinas from a single mouse.
For counting cells in the ganglion cell layer, we captured
digital images taken at 200× magnification using an
Olympus BX40 light microscope (Olympus, Mellville,
NY) with a SONY DXC-390 video camera attachment
(Sony, New York, NY) and imported them into Image Pro
Plus v4.5 (Media Cybernetics, Inc., Silver Springs, MD)
quantification software. Parameters were set to automati-
cally identify cells with round nuclei greater than 4 µm in
diameter and exclude vascular endothelial cells (with
spindle-shaped nuclei) and small densely staining cells
that are common in the mouse retina [68]. The selection
process did not distinguish between ganglion cells and
large amacrine cells, but previous studies have estimated
the proportion of ganglion cells in this layer to be 40–
60% of the neurons present [26,68,69]. The number of
cells present in a minimum of 4 microscopic fields, eachBMC Neuroscience 2007, 8:19 http://www.biomedcentral.com/1471-2202/8/19
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encompassing an area of 0.33 mm2 and taken in the
peripheral to midperipheral region around the 4 quad-
rants of each retina, was counted. In non-experimental
retinas, the total numbers of cells ranged from 2055 –
2913 per field, consistent with previous reports of neuro-
nal cell density in this layer [69]. The numbers of cells
present in each retina was taken as the average of these
counts and cell loss was calculated in each mouse as the
percent change between the control and experimental
eyes. Overall, we counted approximately 10% of the neu-
rons present in each retina, which previous studies have
demonstrated provides an accurate estimate of the loss of
retinal ganglion cells after optic nerve crush [25,26,48].
Ganglion cell number was also estimated in untreated
eyes of DBA/2J and BALB/cByJ mice by axon counting.
Briefly, the optic nerves of 5 eyes from each strain were
harvested and fixed overnight in 2.5% glutaraldehyde in
PBS and then embedded in glycol methacrylate (JB-4 Plus,
PolyScience, Worthington, PA). Transverse sections of 2
µm thick were cut approximately 1 mm from the globe
and stained by silver impregnation to identify axons [67].
Axon counting was conducted as described previously
[36] using 3 sections from each nerve.
Ribonuclease protection assays (RPAs)
Total RNA was isolated from the brains of DBA/2J (n = 24)
or BALB/cByJ (n = 23) mice. Radiolabeled antisense ribo-
probes for RPA were synthesized from linearized pBK-
CMV plasmid (Stratagene, La Jolla, CA) templates con-
taining the terminal 127 nucleotides of the murine Bax
coding region or nucleotides 55–252 of the murine S16
ribosomal protein coding region. Probe synthesis, purifi-
cation, hybridization, and RNase digestion conditions
were as described previously [48]. Because retinas were
used for the quantification of cell loss, RPA assays were
performed on total RNA isolated from brain tissue of
mice. In some mice, however, we confirmed that the level
of Bax mRNA, and the ratio of Bax mRNA to S16 mRNA,
was consistent between the 2 CNS tissues (data not
shown). RPAs were initiated by precipitating 20 µg brain
total RNA for Bax or 1 µg brain total RNA for S16 with 5 ×
105 acid precipitable cpm of probe. After hybridization
and RNase digestion, protected probes were separated on
0.4 mm 8 M urea/6% polyacrylamide gels, and exposed to
BioMax MR film (Kodak, Rochester, NY). Exposure times
ranged from overnight to 10 d at -80°C with an intensify-
ing screen. Band intensities were quantified from densito-
metric scans of multiple exposures of each gel using NIH
Image software, and confirmed by liquid scintillation
counting of the excised bands.
Genotyping mice
Genomic DNA was isolated from the spleens of N2 back-
crossed mice (n = 55) and F2 mice (n = 56) for genotyp-
ing. Bax is located at position 23.0 on chromosome 7.
PCR genotyping analysis was performed for the polymor-
phic marker D7Mit27 using the primers: 5' TGA ACT GGG
GAG GAA AGT TG and 5' AAC ATG AAA AGA CAT TCC
CCC. These primers yielded a 218 bp fragment for DBA/
2J mice and a 182 bp fragment for BALB/cByJ mice and
map within 1.5 Mbp of the mouse Bax gene. PCR products
were separated on 3% Meta Phor Agarose (Cambrex,
Rockland, ME) gels and the bands were identified by
ethidium bromide staining.
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